503A Compounding Pharmacy Probationary Monitoring Consultant

Expert Oversight During Probation, Consent Decrees, & Regulatory Enforcement

Pharmacies, hospitals, and 503Bs facing disciplinary action may be placed on probation by state Boards of Pharmacy. GMP facilities may become subject to FDA consent decrees or warning letters requiring formal remediation and ongoing oversight.

In these high-risk situations, regulators often mandate an independent, board- or FDA-approved consultant to monitor compliance, oversee corrective actions, and report progress throughout the term of enforcement.

 

What’s Included

Fulfill Agency-ordered monitoring requirements

  • Conduct recurring audits to assess compliance with probation or consent terms

  • Provide written reports at required intervals

  • Support site remediation plans, CAPA tracking, and operational turnaround

  • Help you stay operational and regain trust with regulators

Whether you're under board scrutiny or FDA oversight, we provide experienced, defensible support to help you move forward.

 

Our Holistic Approach

 
  • Gap Analysis Audit

  • CAPA Planning

  • Remediation Implementation

  • Education

  • Compliance Report

 
 
Appoint an Independent Monitor